Nutra Pharma Corp (NPHC)

[maverick81]

NPHC - THE VALUE IS NOT DETERMINED BY THE 10Q


We all know that, investors here were not looking for a spectacular 10Q, Longs are invested in the IP.
NPHC had ZERO revenue and traded at A WAY HIGHER MARKET CAP THAN 4M!! .. it held that valuation because of the INTELLECTUAL PROPERTY it owns.


NPHC will explode when it gets proper funding to ramp up marketing and production of its OTC products and proceed further expand trials for all the rest of the drugs in its pipeline


HIGHLIGHTS FROM 10Q:

For the Three Months
Ended March 31,2018


Net sales
$32,476

Cost of sales
$5,859

Gross profit
$26,617


For the Three Months
Ended March 31,2017

Net sales
$16,979

Cost of sales
$7,794

Gross profit
$9,100



GROSS PROFIT INCREASED nearly 300% from last year in Q1.
It would appear to me that NYLOXIN marketing campaign is working! DISTRIBUTION TO THE VA IS bringing growth in sales. I expect to see this continue to grow incrementally through the year.

Seeing this positive growth in sales could be exactly what the JV partners wanted to see. I believe we are very close to some major developments.

The accumulation continues here at these levels for a reason

NPHC


Mav